Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Respiratory

Respiratory (17 companies · 7 conditions)

Conditions

Asthma 5 Acute Respiratory Distress Syndrome 3 Alpha-1 Antitrypsin Deficiency 3 Rare COPD 3 Idiopathic Pulmonary Fibrosis 3 Rare Cystic Fibrosis 2 Rare Obstructive Sleep Apnea 1

Companies

Ticker Company Therapeutic areas In Respiratory Lead stage Programs
FDMT 4D Molecular Therapeutics OphthalmologyRespiratory Rare 2 Phase 3 5
ACRS Aclaris Therapeutics DermatologyRespiratory 1 Phase 2 7
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 1 Approved 10
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 4 Phase 2 9
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 1 7
CLDX Celldex Therapeutics DermatologyImmunology+1 1 Phase 3 7
CNTB Connect Biopharma Respiratory 4 Phase 2 4
IXHL Incannex Healthcare ImmunologyNeurology+1 1 Phase 2 3
KYMR Kymera Therapeutics DermatologyRespiratory Rare 1 Phase 2 4
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 7
OMER Omeros HematologyNeurology+2 Rare 1 NDA Submitted 7
RVPH Reviva Pharmaceuticals CardiovascularDermatology+2 Rare 1 Phase 3 10
GPCR Structure Therapeutics MetabolicRespiratory Rare 1 Phase 2 5
VTVT vTv Therapeutics MetabolicRespiratory Rare 1 Phase 3 8
WVE Wave Life Sciences MetabolicNeurology+1 Rare 1 Phase 2 5
ZYME Zymeworks OncologyRespiratory 1 Approved 11